Quick Answer
GRI Bio, Inc. reported Shares Outstanding of 497.7 thousand shares for fiscal year 2025.
GRI Bio, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 497,693 | +2551.8% |
| 2024 | 18,768 | +545.2% |
| 2023 | 2,909 | -99.3% |
| 2023 | 422,333 | +195.7% |
| 2022 | 142,820 | -97.9% |
| 2021 | 6.81M | +51.2% |
| 2020 | 4.51M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 3.27M | -34.9% | +30.9% |
| June 30, 2025 | 2.50M | +211.4% | +375.3% |
| March 31, 2025 | 525,358 | -83.6% | -0.0% |
| December 31, 2024 | 525,485 | +958.1% | -89.5% |
| September 30, 2024 | 5.02M | +69.9% | +526.4% |
| June 30, 2024 | 801,914 | -72.9% | -74.9% |
| March 31, 2024 | 3.20M | +611.3% | +6336.4% |
| December 31, 2023 | 49,663 | — | -98.3% |
- GRI Bio, Inc. showed an increase of +2551.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, GRI Bio, Inc.’s shares outstanding has declined by 89.0% (from 4.51 million shares to 497.7 thousand shares).
- The most recent figure is from GRI Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: